Journal of Cardiac Arrhythmias最新文献_第6页

Late Electrode Sepsis: Clinical Features, Diagnostics and Management. Clinical Cases 晚期电极败血症:临床特征，诊断和管理。临床病例

Journal of Cardiac Arrhythmias Pub Date : 2021-06-15 DOI: 10.17816/cardar71367

V. Zimina, G. Aĭrapetian, Y. Grishkin, S. Sayganov

{"title":"Late Electrode Sepsis: Clinical Features, Diagnostics and Management. Clinical Cases","authors":"V. Zimina, G. Aĭrapetian, Y. Grishkin, S. Sayganov","doi":"10.17816/cardar71367","DOIUrl":"https://doi.org/10.17816/cardar71367","url":null,"abstract":"Modern cardiology is impossible without implantation of intracardiac devices, such as cardiac pacemakers, resynchronization therapy devices, implantable cardioverter-defibrillators. Meanwhile, as the number of implanted devices increases, so does the number of cases of their infection [1]. At present, sufficient clinical material has been accumulated, demonstrating the obvious features of the course of this type of IE, leading to late diagnosis, the spread of infection to the tricuspid valve and, as a result, to a poor prognosis. The frequency of purulent complications after implantation of pacemakers is from 0.6 to 5.7%; mortality rate varies from 0.13% in local purulent inflammation to 19.9% in bacterial endocarditis and sepsis [2]. \u0000Abroad, term electrode sepsis is widely used to reflect the main features of the course of cardiac implantable electronic device infection, which are the predominance of systemic inflammation symptoms and the long-term absence of heart damage signs. \u0000We present two typical cases of the course of cardiac implantable electronic device infection, illustrating the difficulties of diagnosing and treating this disease.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89166939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Postabaltive Pericarditis in Patient with a Prior History of Rheumatic Disease: a Case Report 既往有风湿病史的患者术后心包炎1例报告

Journal of Cardiac Arrhythmias Pub Date : 2021-06-15 DOI: 10.17816/cardar71371

E. Zhelyakov, A. Ardashev, Amen A. Kocharian, Mikhail L. Ginsburg, E. Daniels

{"title":"Postabaltive Pericarditis in Patient with a Prior History of Rheumatic Disease: a Case Report","authors":"E. Zhelyakov, A. Ardashev, Amen A. Kocharian, Mikhail L. Ginsburg, E. Daniels","doi":"10.17816/cardar71371","DOIUrl":"https://doi.org/10.17816/cardar71371","url":null,"abstract":"A 60 year-old male with a previous (40 years ago) history of rheumatic carditis without valve involvement and 5 years history of paroxysmal atrial fibrillation underwent ablation (PV isolation with roof and mitral isthmus lines). The following day patient developed AF episode with severe mid-sternal chest pain with widespread concave ST elevation throughout most of the limb leads (I, II, III, aVL, aVF) and precordial leads (V2-6). Serum troponin I was 87.2 ng/ml with a creatinine concentration of 0.88 mg/dl and hemoglobin level of 15 g/dl. 2D transthoracic echocardiogram excluded wall motion abnormalities, or significant pericardial effusions. Recurrence of acute rheumatic fever was excluded based on revised Jones criteria. Careful analysis of ECG allowed us to recognize the ECG criteria of pericarditis and to avoid unnecessary emergent coronary angiography. Ultimately, the patient was diagnosed with pericarditis. After diagnosis, the patients presenting symptoms resolved with treatment including sotalol 160 mg per day, nonsteroidal anti-inflammatory agents. \u0000Conclusions: This is the first reported case study of post-cardiac ablation pericarditis in patient with prior history of rheumatic carditis.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83079638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nuances of Cardiac Resynchronization Therapy in Patients with Dilated Cardiomyopathy and Atrial Fibrillation (a Clinical Case) 扩张型心肌病合并心房颤动患者心脏再同步化治疗的细微差别(1例)

Journal of Cardiac Arrhythmias Pub Date : 2021-06-15 DOI: 10.17816/cardar75647

F. Bitakova, V. Gumerova, E. Zbyshevskaya, V. Zimina, T. Novikova, Rodion V. Ratmanov, Sergey A. Saiganov, Vladislava A. Shcherbakova

引用次数: 0

Clinical Experience of Use of Sacubitril/Valsartan in a Patient with Dilated Cardiomyopathy, Chronic Heart Failure with Reduced Ejection Fraction and Ventricular Arrhythmias 舒比利/缬沙坦治疗扩张型心肌病、慢性心力衰竭伴射血分数降低及室性心律失常的临床观察

Journal of Cardiac Arrhythmias Pub Date : 2021-06-15 DOI: 10.17816/cardar65220

V. Snezhitskiy, L. V. Kalatsei, Marina Ch. Matyukevich, S. N. Grib, Elena А. Snezhickaya, G. A. Madekina, Zh. G. Epifanova, E. N. Chernaya

{"title":"Clinical Experience of Use of Sacubitril/Valsartan in a Patient with Dilated Cardiomyopathy, Chronic Heart Failure with Reduced Ejection Fraction and Ventricular Arrhythmias","authors":"V. Snezhitskiy, L. V. Kalatsei, Marina Ch. Matyukevich, S. N. Grib, Elena А. Snezhickaya, G. A. Madekina, Zh. G. Epifanova, E. N. Chernaya","doi":"10.17816/cardar65220","DOIUrl":"https://doi.org/10.17816/cardar65220","url":null,"abstract":"Chronic heart failure is the final stage of the cardiovascular continuum, which is an important cause of disability and reduced life expectancy in developed countries. Optimal medical therapy recommended for patients with symptomatic HF and reduced left ventricular ejection fraction includes angiotensin-converting enzyme inhibitors (or angiotensin II receptor antagonists), beta-blockers and mineralocorticoid receptor antagonists. However, the use of optimal medical therapy does not always lead to the elimination of symptoms, improvement of the quality of life and functional capabilities of patients. \u0000Sakubitril/valsartan is a novel combination drug that includes the angiotensin II receptor blocker valsartan and the neprilisin inhibitor sacubitril. In a large PARADIGM-HF clinical trial it demonstrated a 20% reduction in cardiovascular mortality and hospitalization due to decompensation of heart failure compared with standard therapy with enalapril. We report a case of successful use of sacubitril/valsartan in a 61-year-old patient with dilated cardiomyopathy, chronic heart failure with reduced ejection fraction and ventricular arrhythmias. After 6 months of therapy, the patient achieved marked positive dynamics of the clinical status, laboratory and instrumental parameters in absence of any adverse reactions and complications.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86163498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

The Role of Hyperuricemia in the Development of Atrial Fibrillation 高尿酸血症在房颤发展中的作用

Journal of Cardiac Arrhythmias Pub Date : 2021-06-15 DOI: 10.17816/cardar66609

T. Barysenka, V. Snezhitskiy

引用次数: 1

Incidence of Esophageal Thermal Injury Using a Safety Protocol During Atrial Fibrillation Ablation 心房颤动消融过程中使用安全方案的食管热损伤发生率

Journal of Cardiac Arrhythmias Pub Date : 2020-12-15 DOI: 10.24207/jca.v33i4.3413

A. Borges, G. Gazzoni, J. Yáñez, K. Andrade, Celine de Oliveira Boff, F. V. Ferreira, E. Bartholomay, Á. Rösler, F. Lucchese, C. Kalil

{"title":"Incidence of Esophageal Thermal Injury Using a Safety Protocol During Atrial Fibrillation Ablation","authors":"A. Borges, G. Gazzoni, J. Yáñez, K. Andrade, Celine de Oliveira Boff, F. V. Ferreira, E. Bartholomay, Á. Rösler, F. Lucchese, C. Kalil","doi":"10.24207/jca.v33i4.3413","DOIUrl":"https://doi.org/10.24207/jca.v33i4.3413","url":null,"abstract":"Objective: Catheter ablation has been a common procedure used for the management of atrial fibrillation (AF). Atrioesophagel fistula (AEF) is one of the most feared complications of AF ablation. Although it is a rare complication, severe esophageal thermal injury must be avoided. It is important to describe a safe method of preventing esophageal injuries without increasing AF recurrence. Methods: A retrospective cohort study of consecutive patients who underwent radiofrequency AF catheter ablation during 1 year-period wa conducted. One hundred and four patients were enrolled divided in two groups: one with a maximum recorded esophageal temperature (ET) < 38 °C and other with a maximum recorded ET ≥ 38 °C. The primary endpoint was detection of endoscopic esophageal lesions after AF ablation and the secondary endpoint was AF recurrence according to the maximum ET reached during the procedure. Results: The maximum ET was on average 37.3 ± 1.0 °C. Only 4 (3.8%) patients had esophageal lesion diagnosed by upper gastrointestinal endoscopy. There were no cases of esophageal perforation. The AF recurrence rate was 9.6% during the follow-up (10 patients, 3 from the ET max < 38 °C group and 7 from the ET max ≥ 38 °C group; p = 0.181). The maximum ET was not associated with AF recurrence after catheter ablation (OR = 1.65, 95% CI = 0.84-3.24, p = 0.14). Conclusions: A low incidence of esophageal injury after AF ablation with the use of a specific esophageal protection protocol was found. There was no esophageal perforation. The AF recurrence rate was similar to that described in the literature.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45667029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Brief review of the risks and the stratification of sudden death in the ventricular Pre-excitation syndrome. 心室预激综合征猝死的风险和分层的简要回顾。

Journal of Cardiac Arrhythmias Pub Date : 2020-12-15 DOI: 10.24207/jca.v33i4.3400

Clóvis Fröemming Junior, T. Leiria, G. G. Lima, L. M. Pires, M. Kruse, T. C. Moreira, Javier Pinos, B. Finkler, D. Zanotta

{"title":"A Brief review of the risks and the stratification of sudden death in the ventricular Pre-excitation syndrome.","authors":"Clóvis Fröemming Junior, T. Leiria, G. G. Lima, L. M. Pires, M. Kruse, T. C. Moreira, Javier Pinos, B. Finkler, D. Zanotta","doi":"10.24207/jca.v33i4.3400","DOIUrl":"https://doi.org/10.24207/jca.v33i4.3400","url":null,"abstract":"Objective: The diagnosis of ventricular preexcitation syndromes is often occasional and with underestimated risk, showing controversies in its stratification and indication of prophylactic ablation. This work aims to explore and summarize the data in the literature, exposing the authors’ conclusions regarding this review. Methods: The authors prepared this work based on the latest guideline of the European Society of Cardiology plus a search for articles published in MEDLINE whose titles related to sudden death from ventricular fibrillation in patients with ventricular preexcitation. Discussion: Sudden death secondary to preexcited atrial fibrillation with degeneration to ventricular fibrillation is the most feared event in Wolff-Parkinson-White syndrome, has an average annual incidence of 0.15 to 0.39%, affecting individuals with structurally normal heart. The noninvasive stratification methods do not demonstrate adequate efficacy, and an electrophysiological study is recommended for all cases at the time of diagnosis. The most severe criteria for sudden death are shortest preexcited RR interval ≤ 250 ms (SPERRI or SPRRI); accessory pathway effective refractory period (APERP) ≤ 250 ms; presence of multiple accessory bundles; shortest paced cycle length with preexcitation during atrial pacing ≤ 250ms (SPPCL); Ebstein anomaly; induction of sustained supraventricular tachycardia. Conclusion: The low rate of complications during the diagnostic exam as well as in the therapeutic procedure, added to the high percentage of success of radiofrequency ablation, leads to indicate early the execution of electrophysiological study as a more diligent and accurate measure in the reduction of sudden death events in patients with ventricular preexcitation syndromes.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46740180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

What is the diagnosis? 诊断结果是什么?

Journal of Cardiac Arrhythmias Pub Date : 2020-11-28 DOI: 10.24207/jca.v33i4.3428

Oğuzhan Birdal, Y. Koza, Onur Altınkaya, H. Taş

引用次数: 0

ST-Segment Elevation Associated with Mobitz II Atrioventricular Block During Transseptal Puncture for Atrial Fibrillation Ablation 房颤消融经间隔穿刺时st段抬高与Mobitz II型房室传导阻滞相关

Journal of Cardiac Arrhythmias Pub Date : 2020-11-20 DOI: 10.24207/jca.v33i4.3427

P. D. Vale, L. T. M. Silva, J. Rocha, C. S. Margalho, H. Maia

引用次数: 0

Belhassen Syndrome in Teenager Originating from Left Anterior Fascicle 青少年左前筋膜Belhassen综合征

Journal of Cardiac Arrhythmias Pub Date : 2020-10-24 DOI: 10.24207/jca.v33i4.3417

L. T. M. Silva, P. D. Vale, J. Rocha, C. S. Margalho, H. Maia

引用次数: 0